Fate Therapeutics, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Fate Therapeutics, Inc. – Product Pipeline Review – 2016’, provides an overview of the Fate Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Fate Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Fate Therapeutics, Inc.

The report provides overview of Fate Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Fate Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Fate Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Fate Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Fate Therapeutics, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Fate Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Fate Therapeutics, Inc. Snapshot 5

Fate Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

Fate Therapeutics, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Fate Therapeutics, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Fate Therapeutics, Inc. - Pipeline Products Glance 12

Fate Therapeutics, Inc. - Early Stage Pipeline Products 12

IND/CTA Filed Products/Combination Treatment Modalities 12

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Fate Therapeutics, Inc. - Drug Profiles 15

ProTmune 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Cellular Immunotherapy for Solid Tumors and Hematological Tumors 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Stem Cell Therapy 2 for Undisclosed Indication 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Stem Cell Therapy for Hearing Disorders 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Stem Cell Therapy for Hematological and Solid Tumors 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Stem Cell Therapy for Inflammation and Autoimmune Diseases 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Stem Cell Therapy for Lysosomal Storage Disorder 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Stem Cell Therapy for Solid Tumors and Hematologic Malignancies 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Stem Cell Therapy for Musculoskeletal Disorders 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Stem Cell Therapy 1 for Undisclosed Indication 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Fate Therapeutics, Inc. - Pipeline Analysis 25

Fate Therapeutics, Inc. - Pipeline Products by Molecule Type 25

Fate Therapeutics, Inc. - Recent Pipeline Updates 26

Fate Therapeutics, Inc. - Dormant Projects 27

Fate Therapeutics, Inc. - Discontinued Pipeline Products 28

Discontinued Pipeline Product Profiles 28

FT-1050 28

Fate Therapeutics, Inc. - Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Appendix 30

Methodology 30

Coverage 30

Secondary Research 30

Primary Research 30

Expert Panel Validation 30

Contact Us 30

Disclaimer 31

List of Tables

List of Tables

Fate Therapeutics, Inc., Key Information 5

Fate Therapeutics, Inc., Key Facts 5

Fate Therapeutics, Inc. – Pipeline by Indication, 2016 7

Fate Therapeutics, Inc. – Pipeline by Stage of Development, 2016 8

Fate Therapeutics, Inc. – Monotherapy Products in Pipeline, 2016 9

Fate Therapeutics, Inc. – Partnered Products in Pipeline, 2016 10

Fate Therapeutics, Inc. – Partnered Products/ Combination Treatment Modalities, 2016 11

Fate Therapeutics, Inc. – IND/CTA Filed, 2016 12

Fate Therapeutics, Inc. – Preclinical, 2016 13

Fate Therapeutics, Inc. – Discovery, 2016 14

Fate Therapeutics, Inc. – Pipeline by Molecule Type, 2016 25

Fate Therapeutics, Inc. – Recent Pipeline Updates, 2016 26

Fate Therapeutics, Inc. – Dormant Developmental Projects,2016 27

Fate Therapeutics, Inc. – Discontinued Pipeline Products, 2016 28

Fate Therapeutics, Inc., Subsidiaries 29

List of Figures

List of Figures

Fate Therapeutics, Inc. – Pipeline by Top 10 Indication, 2016 7

Fate Therapeutics, Inc. – Pipeline by Stage of Development, 2016 8

Fate Therapeutics, Inc. – Monotherapy Products in Pipeline, 2016 9

Fate Therapeutics, Inc. – Pipeline by Molecule Type, 2016 25

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports